With Trump’s Tariffs set to go into effect on April 2, this is a critical time for traders.

I’ll level with you here…

It’s understandable you might be nervous about what these tariffs could do to the markets next week. But I’m here to show you that…

Volatility is your friend in these markets.

The truth is many of the best trade opportunities will actually happen BEFORE April 2.

And over the next 5 days, Bryan and I will be giving you 5 “extreme buy” companies that could benefit immensely leading up to and after the tariffs start. By the end of this series, you’ll be fully prepared and confident to make your trades ahead of this major market event.

My first “extreme buy” pick is Recursion Pharmaceuticals (RXRX).

RXRX is an artificial intelligence pharmaceutical company, and it’s using AI to develop pharmaceuticals.

You might ask “what does a big pharma AI company have to do with tariffs?”

The answer is NOTHING, and that’s exactly why RXRX is one of my top picks.

You see… RXRX is currently getting hammered with the rest of the market. Yet its selloff has nothing to do with the tariff situation.

As you’ll see in the chart above, RXRX has been dropping to lower levels (around $6 as of this writing).

But it’s even more crucial to notice the overall “pattern” of its chart.

Do you see how it has multiple “bottoms” right in the $6-7 range? And every time it nears $6-7, it bounces back. Can you see how that could lead to multiple buying opportunities?

The reason the bottoms are occurring is when the markets get volatile, people panic and sell everything. It’s an understandable emotional reaction. But it’s also irrational because companies like RXRX have nothing to do with why the market is moving down.

So when I notice a stock like RXRX is selling off, I ask myself…

“Why is this stock selling off? Does it have anything to do with the tariff news?” If my answer is “no,” then I know this could be an overreaction.

In fact, just a couple weeks ago, RXRX was down right around $6 and then it jumped to $10 in a matter of weeks.

The insiders are also noticing this…

RXRX has seen strong insider buying from Softbank and other major institutions. Notable investor Cathie Wood also recently bought 653,000 shares in early January.

Trading veterans like Wood and Warren Buffet aren’t sitting on their hands when the markets get volatile like they are now. They’re eyeing the best companies at a discount.

And I believe RXRX is one of those companies.

With its bounce potential, I’m projecting a 71% stock gain for RXRX this year. And I believe now is the time to get positioned before the critical “tariff event” goes into effect next week.

YOUR ACTION PLAN

I’ve already closed multiple winning trades on RXRX so far in 2025, including a 21.3% winner in 30 trading days. And right now its nearing its support bottom at around $6.

When we say we thrive in volatile markets like these, we’re not just blowing smoke.

So far in 2025, we’ve closed 60 trades for winners for an 81% win rate.

And if you want to see our exact strategies for discounted-stocks like RXRX, we invite you to watch our “Tariff Emergency Prep Briefing.”

This video will help you get ahead of everyone else, and give you plenty of options for trades before the tariffs go into full effect.

Don’t look back on these times and “wish you bought more.”

Click here to unlock our trading plan for tariffs today.